Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India
Open Access
- 18 January 2009
- journal article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 14 (1), 88-92
- https://doi.org/10.1111/j.1365-3156.2008.02195.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?Nature Reviews Microbiology, 2007
- Phase 4 Trial of Miltefosine for the Treatment of Indian Visceral LeishmaniasisThe Journal of Infectious Diseases, 2007
- Injectable Paromomycin for Visceral Leishmaniasis in IndiaThe New England Journal of Medicine, 2007
- Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980–2004The Lancet Infectious Diseases, 2005
- Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid FormulationsClinical Infectious Diseases, 2004
- Oral Miltefosine for Indian Visceral LeishmaniasisThe New England Journal of Medicine, 2002
- Socio-economics of visceral leishmaniasis in Bihar (India)Transactions of the Royal Society of Tropical Medicine and Hygiene, 2000